INTRODUCTION {#s1}
============

To date, the genus *Mycobacterium* comprises over 160 species (<http://www.bacterio.cict.fr/>). Several species other than *M. tuberculosis*, nontuberculous mycobacteria (NTMs), are becoming increasingly recognized as significant human pathogens ([@R1]). In the last decade, the rapid development of molecular techniques has led to a great increase in our knowledge about mycobacterial identification and typing ([@R2]). Methods for identification and typing of mycobacteria include nucleic acid probes ([@R3]), PCR hybridization with species-specific probes ([@R4], [@R5]), PCR restriction fragment length polymorphism analysis ([@R6], [@R7]) and nucleic acid sequencing ([@R8]). Identification of *Mycobacterium* species by conventional methods including growth characteristics and biochemical tests are time-consuming and often not unequivocal in their interpretation ([@R2], [@R8]). Currently, the widely accepted strategy formulated to improve methods of mycobacterial strain identification includes analysis of the gene encoding 16S rRNA, however this technique is unable to differentiate members of several closely related species called complex groups a result of small number of polymorphic positions within the 16S rRNA ([@R8]- [@R10]).

Several studies have shown that sequencing of 16S-23S Internal Transcribed Spacer (ITS) gene sequencing could help to differentiate and identify the closely related mycobacterial species ([@R11], [@R12]). Studies aiming at the assessment of heterogeneity within *M. fortuitum* group have used different approaches, from phenotypic methods, conventional typing such as PFGE and ERIC, *hsp65*-PRA and sequence based approaches ([@R13]- [@R17]).

Taxonomic status of species belongs to *M. fortuitum* group clearly addressed by sequencing methods ([@R9]). However, the possible correlation between the pathogenicity of the clinical isolates of *M. fortuitum* subsp. fortuitum in the host and their genotypes has not been extensively evaluated. Distinct ITS sequences namely sequevar found in the *M. avium* complex demostrated that the ITS region is suitable for differentiating strains within some mycobacterial species and has the potential to be used as a marker to distinguish clinically relevant subspecies ([@R11], [@R12], [@R18]).

In this study the ITS sequences of 48 Iranian *M. fortuitum* clinical isolates from different regions were investigated to understand the genetic diversity of the strains and their presumptive relationships with different clinical presentation of disease caused by this organism in Iran.

MATERIALS AND METHODS {#s2}
=====================

Bacterial strains {#s2a}
-----------------

Mycobacterial strains investigated in the present study included 48 clinical isolates of Iranian *M. fortiutum*, which had been isolated in or referred to our laboratory, at Research Center for Infectious Diseases, Ahvaz, Iran. Case subjects were considered for inclusion if they met the 1997 American Thoracic Society criteria for NTM disease ([@R19]). [Table 1](#T1){ref-type="table"} summarises patients' histories. The strains were collected or recovered from the symptomatic patients during 2010-2013.

Identification of isolates by phenotypic tests {#s2b}
----------------------------------------------

Isolates were initially screened using conventional phenotypic tests including standard morphological and biochemical assays previously established for identification of mycobacteria ([@R20]).

DNA extraction and purification {#s2c}
-------------------------------

Chromosomal DNA was extracted using a method of Pitcher *et al.* ([@R21]) with a slight modification to facilitate the susceptibility of cells to the standard digestion. In brief, after thermal inactivation, a pretreatment of biomass with lipase (Type VII; final concentration, 2 mg/ml \[Sigma\]) and a further treatment with proteinase K (100 pg/ml) and sodium dodecyl sulfate (final concentration, 0.5% \[wt/vol\]) were applied. The DNA was purified by phenol chloroform-isoamyl alcohol and precipitated with isopropanol. The precipitate was washed in 70% ethanol, dehydrated and dissolved in 100 μl of Milli-Q water and stored at -20°C freezer until use.

Identification of isolates to species level {#s2d}
-------------------------------------------

The identity of the isolates as *M. fortuitum* was confirmed by PCR restriction fragment length polymorphisem analysis (PRA) of 441 base pairs region of the 65-kDa heat shock protein gene (*hsp65*) by two restriction endonuclease including *BstE*II and *Hae*III as described previously ([@R16]). Representative isolates (randomly selected strains) from each genotype based on ITS region further identified by 16S rRNA sequencing ([@R8]).

ITS gene sequencing {#s2e}
-------------------

All *M. fortuitum* clinical isolates were subjected to the ITS region amplification and sequencing following the procedures described herein ([@R22]). Amplification of the full ITS segment was performed with primers L (5'- GCTGGATCACCTCCTTCT-3') from conserved sequence at the 3' end of the 16S rRNA (from position 1525 to position 1543 on the *Escherichia coli* 16S rRNA) and R (5'- CTGGTGCCAAGGCATCCA-3') which deduced from conserved sequence of 23S rRNA 5' sequences (position 23 to position 40 on the *E. coli* 23S rRNA). Mixture reaction (50μl) containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl~2~, 200 μM (each) deoxynucleoside triphosphate (dATP, dGTP, dCTP, and dUTP), 10 pmol of each primer, 0.5U of Taq DNA polymerase, and 5 μl (50 ng) of extracted DNA using recommended thermal profile. The purified PCR products were directly sequenced with the forward 16S-1511f and reverse 23S-23r primers using an ABI 3100 genetic analyzer and a BigDye Terminator cycle sequencing kit by SEQLAB Company (Germany).

Data analysis of ITS gene sequences {#s2f}
-----------------------------------

The obtained sequences of ITS region of each strain were aligned with the published ITS region sequences of *M. fortuitum* type strains and clinical strains (retrieved from GenBank™ database) using the jPhydit software package according to primary-structure ([@R23]). Comparative analyses of ITS region was performed with distance matrix, maximum-parsimony, and maximum-likelihood methods as implemented in the Mega4 program ([@R24]). Tree topologies was tested by bootstrap analysis on 1000 resampling.

The GenBank accession numbers of ITS sequences of clinical isolates of *M. fortuitum* determined in this work are as follows: KF366424 - KF366435.

RESULTS {#s3}
=======

Based on growth characteristics, 48 isolates were rapidly growing mycobacteria (RGM). The isolates were initially classified into Runyon's groups IV ([@R20]) and further identified by *hsp65*-PRA method as *M. fortuitum* ([Table 1](#T1){ref-type="table"}).

Analysis of the *hsp65* gene by PRA (PCR restriction fragment length polymorphism analysis) (explain PRA for first time) demonstrated identical electrophoretic patterns from clinical isolates (*BstE*II pattern 235/120/85 and *Hae*III pattern 145/120/60/55) to that *M*. *fortuitum* pattern (<http://app.chuv.ch/prasite>). Randomly selected strains from each genotypes of ITS region, identified as *M. fortuitum* species by 16S rRNA sequence analysis.

PCR amplification of the ITS region with the primers L and R resulted in detection of a single band of approximately 380 bp. No variation in product length was considerable between strains.

Twelve different sequence types (sequevar) were identified based on ITS region. Of these 7 had been previously described and these include MfoA, MfoB, MfoC, MfoD, MfoE, MfoF and MfoG identified ([@R11]) but five novel sequevars designated as MfoH, MfoI, MfoJ, MfoK and MfoL were identified among different Iranian clinical strains of *M. fortuitum*. These novel sequevar were distinct from the first group.

Pairwise comparisons between the previously reported sequevar and clinical isolates displayed higher sequence variation between *M. fortuitum* strains. A dendrogram based on maximum parsimony analysis reflecting the ITS sequence-based clustering of all test strains of *M. fortuitum* is shown in [Fig. 1](#F1){ref-type="fig"}. Within the consensus tree, twelve clusters with distinct branches among the *M. fortuitum* reference strains could be defined.

Of 48 test strains, 25 (52%) grouped and formed distinct clusters with previously reported sequevars ([@R11]). The branches was supported with highest bootstrap value (100%) ([Fig 1](#F1){ref-type="fig"}).

Among previously reported sequevars, MfoB (8 isolates, 16.8%) was the most frequently encountered, followed by MfoA (6 isolates, 12.5%) and MfoC (4 isolates, 8.3%). Two isolates (4%) belong to each sequevars MfoD (Mf 24, Mf 53), MfoE (Mf 11, Mf 52) and MfoF (Mf 9, Mf 25) were identified. One isolate (Mf 39), showed identical ITS sequence, to that of reported for MfoG.

Of 48 test strains, 23 (48%), represented novel sequevars and took five well-supported and distinct positions on the ITS tree ([Fig. 1](#F1){ref-type="fig"}). Among the new sequevars reported in this study, MfoH (9 isolates, 18.7%) was the most frequently encountered followed by MfoL (6 isolates, 12.5%), MfoJ and MfoK (4 isolates, 8.3%) and MfoI (2 isolates, 4%).

Twenty-eight isolates (58%) were recovered from the patients with pulmonary disease ([Table 1](#T1){ref-type="table"}). However, the significant association between *M. fortuitum* sequevars and pulmonary disease was not detected.

DISCUSSION {#s4}
==========

The main aim of this study was to access genetic diversity of *M. fortuitum* clinical isolates using ITS sequence analysis. Due to high polymorphism, ITS region has been reported as alternative target for molecular identification of mycobacteria to species level ([@R11], [@R12], [@R18]). ITS region also showed potential utility for strain differentiation among some species of mycobacteria ([@R11], [@R12], [@R17]). Some studies have reported a correlation of the genomic variants and particular host range in mycobacteria, indicating the usefulness of genetic markers including ITS, IS901, major polymorphic tandem repeat (MPTR) and *hsp65* in the subspecies differentiation ([@R11], [@R12], [@R16]-[@R18], [@R22], [@R25], [@R26]). For example, Stout *et al*. (2008), found a significant association between *M. avium* sequence types of ITS region and *M. avium* pulmonary disease ([@R27]).

Different variant of *M. fortuitum* also had been characterized by *hsp65*-PRA or other genetic marker ([@R11], [@R12], [@R14]-[@R16]) but relevance and clinical importance of these genotypes have been poorly studied. *M. fortuitum* is most frequently encounterd species of NTM that usually implicated in chronic infectious diseases caused by mycobacteria in the Iranian clinical settings ([@R28]). Different sequevars reported here, were recovered from wide types of clinical samples including BAL, Blood, Bone marrow biopsy, brain abscess, leg abscess, oral ulcers, sputum and wound infection.

This study demonstrates that the ITS of the *M. fortuitum* exhibits high variations, base substitutions and insertion or deletion. Present study suggests that higher degree of variation at ITS region is valuable for discriminating of clinical strains of *M. fortuitum*. However, no association was found between any particular sequence types and case status.

In conclusion, the ITS region of the genus *Mycobacterium* exhibits a high variation which is discriminative for related taxa. The marker has sufficient power to differentiate and separate clinical strains of *M. fortuitum*. This study showed that the ITS region possesses high discriminatory power between the clinical isolates up to the clonal level. The results also suggest the possibility of the existence of predominant clone of *M. fortuitum* in affected patients in Iran. The data also point to the conclusion that a large variety of *M. fortuitum* clone can produce human disease although certain clones seem to be predominant.
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###### 

Characteristics of 48 Clinical isolates of Iranian *M. fortuitum*

  Strains (Mf)   Sample source         G/A^a^   PMH                               Main symptoms                                 Chest X-ray                            Diagnosis by clinical findings   ITS sequevars[\*](#TFN2){ref-type="table-fn"}
  -------------- --------------------- -------- --------------------------------- --------------------------------------------- -------------------------------------- -------------------------------- -----------------------------------------------
  7              Leg abscess           F (66)   Healthy                           Subcutaneous abscesses                        ND                                     Tb                               K
  9              BAL                   F (64)   Kidney transplant recipient       Fever, cough                                  Irregular nodular lesions              Tb                               F
  10             BAL                   M (59)   COPD                              Fever, cough                                  Cavitation                             Tb                               A
  11             Wound infection (2)   F (62)   HIV                               Fever, weight loss                            NA                                     Tb                               E
  12             BAL                   M (34)   Chronic lymphocytic leukemia      Dyspnea, cough                                Pleural effusion                       Tb                               C
  13             Biopsy                M (19)   Soft tissue abscess               Subcutaneous nodules                          ND                                     Tb                               A
  14             Blood                 M (44)   BMT                               Fever, weight loss                            ND                                     ND                               K
  15             BAL                   F (71)   Chronic bronchitis                Dyspnea, cough                                Bilateral involvement                  Tb                               H
  16             Blood                 F (47)   BMT                               Fever, weight loss                            ND                                     Fungal infection                 A
  18             Sputum (3)            F (66)   COPD                              Dyspnea                                       Consolidative with pleural effusions   Tb                               A
  22             BAL                   F (71)   HIV                               Fever, cough                                  Pleural effusions                      Tb                               H
  23             Soft tissue biopsy    M (45)   Healthy                           \-                                            \-                                     ND                               B
  24             Oral ulcers           M (32)   Pamphlgus                         Oral ulcers                                   \-                                     ND                               D
  25             Blood                 F (47)   HIV                               Fever                                         ND                                     ND                               F
  28             BAL                   F (72)   Recurrent CMV, HIV                Fever, cough                                  Cavitation                             Tb                               B
  29             BAL                   F (71)   Healthy                           Fever, cough                                  Infiltrates                            Tb                               B
  30             Sputum and BAL        M (42)   HIV                               Fever, general weakness and dysuria           Infiltrates                            Tb                               H
  31             BAL                   F (65)   Kidney transplant recipient       Fever, cough                                  Diffuse pneumonic infiltrates          Tb                               A
  32             Brain abscess         M (32)   Brain abscess                     FUO                                           NA                                     Nocardiosis                      C
  35             Leg discharges (2)    M (49)   DM                                Swelling left leg, purulent wound discharge   ND                                     Mycetoma                         L
  39             BAL                   F (67)   Tb                                Fever, cough                                  Cavitation                             Tb                               G
  40             BAL                   F (31)   Healthy                           Fever, chest pain, cough                      Nodule                                 Tb                               L
  41             Blood                 M(66)    Mitral valve prosthesis           Post operative fatigue, chest pain            ND                                     ND                               I
  42             BAL                   F (81)   Neo                               Fever, chest pain, cough                      Infiltrate                             Tb                               A
  43             Sputum (3)            M (62)   Ischemic heart disease            Fever, cough                                  Small irregular nodular lesions        Tb                               H
  47             BAL                   M (67)   Chronic bronchitis                Fever, cough                                  Diffuse pneumonic infiltrates          Tb                               J
  48             BAL                   M (59)   Chronic bronchitis                Fever, cough                                  Diffuse pneumonic infiltrates          Tb                               C
  49             Sputum, BAL           M (42)   Follicular non-Hodgkin Lymphoma   Dyspnea, cough                                Bilateral involvement                  Tb                               H
  50             Brain abscess         M (59)   Brain abscess                     FUO, weight loss, headache                    CT scan, cerebral abscess              Nocardiosis                      J
  51             BAL                   F (47)   Healthy                           Fever, chest pain, weight loss                Cavitation                             Tb                               H
  52             BAL                   F (55)   Healthy                           Fever, chest pain, cough                      Nodule                                 Tb                               E
  53             Biopsy                F (18)   Skin graft recipient              Weakness, soft tissue abscess                 NA                                     Nocardiosis                      D
  54             Biopsy                F (28)   Soft tissue abscess               Subcutaneous nodules                          ND                                     Mycetoma                         I
  55             BAL                   F (81)   Tb                                Fever, cough                                  Cavitation                             Tb                               B
  56             Blood                 M (32)   Liver transplant recipient        FUO                                           ND                                     ND                               L
  68             Brain abscess         F (64)   Brain abscess                     FUO, weight loss, headache                    CT scan, cerebral abscess              Nocardiosis                      L
  71             Sputum (3)            F (64)   Tb, HIV                           Fever, cough                                  Cavitation                             Tb                               L
  77             Brain abscess         F (50)   Multifocal brain abscesses        FUO, headache                                 CT scan, cerebral abscess              Nocardiosis                      B
  78             Sputum                M (88)   Neo                               Chest pain                                    Cavitation                             Tb                               H
  79             Bone marrow biopsy    M (14)   Hemophili                         Fever, Dyspnea, cough                         ND                                     Tb                               K
  84             BAL                   F (73)   Neo                               Fever, chest pain, weight loss                Infiltrate                             Tb                               B
  90             Sputum (4)            M (48)   Neo                               Fever, cough, chest pain                      Cavitation                             Tb                               C
  SM25           BAL                   M (63)   Liver transplant recipient        Fever, cough                                  Small irregular nodular lesions        Tb                               J
  SM26           BAL                   F (42)   Tb, HIV                           General weakness, dysuria                     Cavitation                             Tb                               L
  SM30           BAL                   F (21)   Follicular non-Hodgkin Lymphoma   Fever , cough                                 Diffuse pneumonic infiltrates          Tb                               H
  SM62           Blood                 F (46)   Kidney transplant recipient       FUO                                           ND                                     ND                               H
  SM80           BAL                   F (73)   Neo                               Fever, chest pain, weight loss                Infiltrate                             Tb                               B
  SM84           BAL                   F (40)   Neo                               Fever, chest pain, weight loss                Infiltrate                             Tb                               B

Abbreviations: G/A, gender/age; PMH, past medical history; F, female, ND, not determined; BAL, bronchoalveolar lavage; M, Male; COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; NA, not available; BMT, bone marrow transplantation; CMV, cytomegalovirus, FUO, fever unknown origin, DM, diabetes mellitus; Tb, tuberculosis; Neo, neoplasia, CT, computed tomography.

ITS sequevars from A to G has been reported previously (9) and H to L reports as new genotypes base of ITS sequences.
